Title : Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer.

Pub. Date : 2015 Feb

PMID : 25434755






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study aimed to evaluate the biological functions of excision repair cross complementation goup 1 (ERCC1) in cell proliferation, cell cycle, invasion and cisplatin response of non-small cell lung cancer (NSCLC) cells. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
2 This study aimed to evaluate the biological functions of excision repair cross complementation goup 1 (ERCC1) in cell proliferation, cell cycle, invasion and cisplatin response of non-small cell lung cancer (NSCLC) cells. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
3 In the present study, the results demonstrated that ERCC1 had no effect on cell proliferation, cell cycle and the ability of invasion, but showed significant impact on cisplatin response of the NSCLC H1299 cells. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens
4 Furthermore, siRNA-induced suppression of ERCC1 evidently enhanced sensitivity to cisplatin of NSCLC A549 cells. Cisplatin ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens